Health, Medical & Pharma News - Updated Daily page 19

Will We Have Fewer Doctors of Color?

Medical schools have experienced a steep decline in enrollment among Black and Hispanic students since the Supreme Court banned the consideration of race in adm

Are Young People With Eating Disorders Predisposed to Them?

Eating disorders appear to be linked to differences in brain structure among teenagers. Young adults who develop eating disorders appear to have delayed brain m

U.S. Dementia Cases Expected to Double By 2060

Seniors risk of dementia is more than double what was previously thought. The risk of developing dementia after age 55 is more than 42 among Americans, research

Bird Flu Kills 20 Million Chickens in U.S., Driving Egg Prices Sky-High

A deadly bird flu outbreak has wreaked havoc on U.S. chicken farms, claiming the lives of over 20 million egg-laying chickens last quarter, marking the worst im

How To Handle Travel Stress

as they cause instability and can exacerbate feelings of anxiety. Consider exercising before your trip begins. The endorphins from exercise will calm you down a

Perioperative GLP-1 RA Use Reduces Risk for Complications in Patients With Diabetes

For patients with diabetes undergoing a surgical procedure, an active perioperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescription is associat

Rurality Partly Explains Racial Difference in Distance to Lung Cancer Screening

Differences in distance to lung cancer screening (LCS) facilities by race and ethnicity are partly explained by rurality, according to a study published online

Postdischarge Contacts Do Not Reduce 30-Day ED Visits, Readmissions

Postdischarge contacts (PDCs) with patients after hospitalization are not associated with reductions in 30-day emergency department use or 30-day readmissions,

FDA Adds Warning Label to RSV Vaccines Abrysvo and Arexvy

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information for the Abrysvo (Pfizer) and Arexvy (

Datopotamab Deruxtecan Granted Priority Review in the US for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer

AstraZeneca and Daiichi Sankyo s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted and granted Priority Review in the

Pharmaceutical News and Articles